Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01875237 · OUTCOME

To Assess the Incidence of Epstein-Barr Virus -PTLD or EBV Reactivation Requiring Therapy Post DLI.

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene · Source last updated 2019-07-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
1 year

What was measured

To assess the incidence of Epstein-Barr virus (EBV)-associated lymphoproliferative disorder or EBV reactivation requiring therapy post DLI.

Analysis population: all patients who received DLI

Groups in this outcome

Transplant Only

Patients who did not move forward to DLI

Transplat Plus DLI

Proceeded to DLI per protocol

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Transplant Only0
Transplat Plus DLI1

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Transplant Only0Not reportedNot reportedNot reportedNot reported
Transplat Plus DLI1Not reportedNot reportedNot reportedNot reported
Complete source fields
calculate Pct
false
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        1
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    2. group Id
      OG001
      value
      1
    units
    Participants
description
To assess the incidence of Epstein-Barr virus (EBV)-associated lymphoproliferative disorder or EBV reactivation requiring therapy post DLI.
groups
  1. description
    Patients who did not move forward to DLI
    id
    OG000
    title
    Transplant Only
  2. description
    Proceeded to DLI per protocol
    id
    OG001
    title
    Transplat Plus DLI
param Type
COUNT_OF_PARTICIPANTS
population Description
all patients who received DLI
reporting Status
POSTED
time Frame
1 year
title
To Assess the Incidence of Epstein-Barr Virus -PTLD or EBV Reactivation Requiring Therapy Post DLI.
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice